Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rankning i aktier #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Aktiekurs
$0.4018
Marknadsvärde
$14.12M
Förändring (1 dag)
-3.20%
Förändring (1 år)
-88.15%
Land
US
Handel Skye Bioscience, Inc. (SKYE)

Kategori

Aktiekurshistorik för Skye Bioscience, Inc. (SKYE)
Högsta slutkurs: $0.50 den 2026-08-01

Lägsta slutkurs: $2.50K den 2014-11-01
Aktiekurshistorik för Skye Bioscience, Inc. från 2014 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 27.55%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$532.17 36.50%
US
$1.00K 51.81%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE